Skip to content

Hippocampal Plasticity of Young Adults With Childhood Adversity

Hippocampal Plasticity of Young Adults With Childhood Adversity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02816502
Enrollment
73
Registered
2016-06-28
Start date
2017-06-15
Completion date
2020-07-07
Last updated
2021-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

childhood, adversity

Brief summary

This study investigates the clinical and neural effects of stress management skill building programs for young adults with childhood adversity. The investigators will recruit a total of 60 young adults (21-35 years old) who will be randomized into two different stress management skill building programs, both of which are 8 weeks long. MRI and psychological assessments will be acquired from all subjects before and after the intervention programs in order to investigate changes in clinical symptoms (such as depression, anxiety and stress) and hippocampus structure and function as well as other neural changes.

Interventions

BEHAVIORALStress Management Skill Building Program A

Subject will meet with the instructor and other students in the group once a week and complete homework and track amount of practice during the week.

BEHAVIORALStress Management Skill Building Program B

Subject will meet with the instructor and other students in the group once a week and complete homework and track amount of practice during the week.

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Mclean Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* having childhood adversity * no history of psychiatric disorders of psychotic features or neurological disorders * verified age between 21-35 years old; * no suicidal attempts during the past six months; * being determined by the clinician to have the capability to comply with the program requirements and not detrimental to other participants in the group; * passing MRI eligibility criteria. * provided written informed consent to participate in this study; * committed to meeting the requirement of refraining from using marijuana or illicit drugs.

Exclusion criteria

* psychosis * active suicidal attempts during the past 6 months * psychoactive substance abuse * MRI

Design outcomes

Primary

MeasureTime frame
Changes in hippocampal subfield gray matter density measured with high resolution structural MRI at 3Tbefore and after the 8-week intervention

Secondary

MeasureTime frame
Changes in stress level measured by the Perceived Stress Scale (PSS)before and after the 8-week intervention
Changes in severity of depression symptom measured by Beck Depression Inventory (BDI)before and after the 8-week intervention
Changes in severity of anxiety symptom measured by State-Trait Anxiety Inventory (STAI)before and after the 8-week intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026